1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow 4Living Biotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb) Plerixafor 20 MG/ML [Mozobil], Placebo - COVID-19 Acute Respiratory Distress Syndrome, COVID-19 | Phase 2 | Withdrawn | 4Living Biotech | 2022-07-19 | 2023-04-10 |
COVID-19 (1)
plerixafor (1)
Bulgaria (1) · France (1)